Federal Court Rejects PhRMA Challenge to Medicare Drug Price Negotiation

Medicare update: Court rules on seniors' drug price negotiations

The decision from the U.S. Court of Appeals for the Fifth Circuit rejected a lawsuit brought by the PhRMA.

Appeals Court Upholds Medicare Drug Price Negotiation Program

The Medicare Drug Price Negotiation Program survived an attempt to nullify it on Aug. 26 as a federal appeals court unanimously rejected a constitutional challenge to the program’s validity.  The case was brought by Pharmaceutical Research and Manufacturers of America, a major trade organization representing major drug companies, along with the National Infusion Center Association and the Global Colon Cancer Association. The organizations argued…

Federal court rejects PhRMA challenge to Medicare drug price negotiation

A federal appeals court on Wednesday ruled against a lawsuit filed by representatives of the pharmaceutical industry challenging the federal Medicare drug price negotiation program, finding that drugmakers are not entitled to sell their products to Medicare at a price they would prefer. The U.S. Court of Appeals for the 5th Circuit affirmed a prior…